|8.27||-0.88 / -9.67%|
Data as of 3:59pm ET
|8.28||+0.015 / +0.18%|
The 6 analysts offering 12-month price forecasts for Horizon Pharma Inc have a median target of 20.50, with a high estimate of 31.00 and a low estimate of 9.00. The median estimate represents a +148.03% increase from the last price of 8.27.
The current consensus among 6 polled investment analysts is to Buy stock in Horizon Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.